Mankind Pharma shares: Antique cuts price target to Rs 1,539 post maiden quarterly results

Mankind Pharma’s branded prescription business grew 18 per cent YoY in Q4 , driven by core therapies of Anti-Infective, Respiratory and GI. Its Consumer Healthcare business grew 10 per cent YoY on account of higher rural penetration.

Related Keywords

India , ,Antique Stock Broking ,Mankind Pharma ,Consumer Healthcare ,Mankind Pharma Shares ,Mankind Pharma Share Price ,Mankind Pharma Stock Price ,Mankind Pharma News ,